FDA’s Regulation on the Use of Social Media

This seminar will help you understand in detail the application of FDA’s guidance on the use of social media in presenting and promoting information about drug products and medical devices subject to FDA regulation. This is critical in order to develop the appropriate strategy, policies and procedures to ensure compliance.

Areas Covered in the Session :
Pros and cons of using social media venues
Compliant use of Social Media in an FDA-regulated Environment
FDA draft guidance documents
Balancing benefit and risk information on social media
Managing character space limitations on social media
Managing misinformation posted by independent third-parties
Pending regulatory action by the US Congress

Who Will Benefit:
Information Technology Managers and Analysts
Medical Affairs Managers and Analysts
Clinical Data Managers and Analysts
Marketing Managers and Analysts
Compliance Managers and Analysts
Regulatory Affairs Managers and Analysts
GMP Training Specialists
Business Stakeholders responsible for product presentation and promotional content
Consultants working in the life sciences industry who are involved in product presentation and promotional content
This webinar will also benefit any consultants working in the tobacco or life science industries who are involved in computer system implementation, validation and compliance.

Carolyn Troiano

Carolyn Troiano has more than 30 years of experience in computer system validation in the pharmaceutical, medical device, animal health, tobacco and other FDA-regulated industries. She is currently an independent consultant, advising companies on computer system validation and large-scale IT system implementation projects.

During her career, Carolyn worked directly, or on a consulting basis, for many of the larger pharmaceutical companies in the US and Europe. She developed validation programs and strategies back in the mid-1980s, when the first FDA guidebook was published on the subject, and collaborated with FDA and other industry representatives on 21 CFR Part 11, the FDA’s electronic record/electronic signature regulation.

Carolyn has participated in industry conferences. She is currently active in the PMI, AITP, and RichTech, and volunteers for the PMI’s Educational Fund as a project management instructor for non-profit organizations.



  • Login Information with Password to join the session, 24 hours prior to the webinar
  • Presentation Handout in .pdf format
  • Presentation from the Speaker
  • Feedback form
  • Certificate of Attendance
  • Recording access Information with Password to view the webinar, will be sent 24 hours after the completion of the Live webinar.
  • Presentation Handout in .pdf format
  • Certificate of Attendance